How might a company in a traditional sector like pharmaceuticals avoid the pitfalls experienced by Theranos?

To prevent similar corporate scandals, the lessons from "Bad Blood" can be implemented in several ways. Firstly, companies should ensure transparency in their operations and maintain open communication with their stakeholders. Secondly, they should have robust internal controls and governance structures to detect and prevent fraudulent activities. Thirdly, companies should foster a culture of ethical behavior and integrity. Lastly, they should not over-promise and under-deliver, as this can lead to unrealistic expectations and eventual downfall.

The story of Theranos has had a significant impact on corporate strategies and business models in Silicon Valley. It served as a cautionary tale about the dangers of overhyping a product and misleading investors, which has led to increased scrutiny and skepticism towards startups with bold claims. It has also highlighted the importance of corporate governance, transparency, and the need for companies to have a viable, tested product before going public. This has resulted in a shift towards more responsible and sustainable business practices in the tech industry.